FEMY
Femasys Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$2.98
−2.61%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$0.47
- Revenue estimate
- $810.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.33
- EPS estimate
- -$1.31
- Revenue actual
- $331.8K
- Revenue estimate
- $730.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +51.7%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $10 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026